Article
Further Personalizing Medicine in Immune Disorders: Genomic Findings and Hematopoietic Cell Transplantation Survival.
Transplantation - 1 Jan 2026
Similuk Morgan N, Bannon Sarah A, Yan Jia, Ghosh Rajarshi, Damskey Ekaterina E, Beers Breanna J, Orellana Halyn, Byers Sophie, Srinivasan Sruthi, Kamen Michael J, Jodarski Colleen, Moses Rachel G, Reynolds-Lallement Nadjalisse C, Lewis Katie L, Seifert Bryce A, Tokita Mari J, Lack Justin B, Cao Wenjia, Sissung Tristan M, Figg William D, Dimitrova Dimana, Kanakry Jennifer A, Hickstein Dennis D, Shah Nirali N, Gonzalez Corina E, Hughes Thomas E, Zerbe Christa S, Su Helen C, Freeman Alexandra F, Uzel Gulbu, De Ravin Suk See, Kang Elizabeth M, Malech Harry L, Rao V Koneti, Lisco Andrea, Fuss Ivan J, Cohen Jeffrey I, Durkee-Shock Jessica R, Delmonte Ottavia M, Bergerson Jenna R E, Johnston Jennifer J, Biesecker Leslie G, Kuijpers Taco W, Notarangelo Luigi D, Holland Steven M, Walkiewicz Magdalena A
Abstract excerpt
BACKGROUND: Hematopoietic cell transplantation (HCT) provides effective long-term management for some inborn errors of immunity. Genetic findings can inform donor selection, considerations in conditioning intensity and agents, and graft-versus-host disease prophylaxis. Exome/genome sequencing is increasingly accessible but of uncertain clinical utility. We aimed to evaluate the clinical utility of comprehensive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.